MEDVi, a national telehealth service, is promoting weight‑loss treatment plans that include prescription GLP‑1 medications such as semaglutide and tirzepatide. The company markets its programs as a convenient, lower‑cost alternative to traditional in‑person care, emphasizing that patients do not need health‑insurance coverage to enroll.
How the program works
Prospective members complete an online health questionnaire and are matched with a licensed medical provider who determines eligibility for GLP‑1 therapy. Once approved, the provider writes a prescription and the medication is shipped directly to the patient’s home. Each monthly package includes the drug, shipping, required lab work and telehealth support for follow‑up visits.
Pricing details
MEDVi’s pricing varies by the specific GLP‑1 product prescribed. For compounded formulations, the introductory rate for the first month is $179. After the initial month, the standard monthly cost rises to $299 for compounded semaglutide injections or pills, and $399 for compounded tirzepatide injections or pills. Branded medications such as Ozempic and Wegovy are billed at a flat monthly rate that typically falls between $1,000 and $1,400, depending on the pharmacy, dosage and supply.
All prices are presented as all‑inclusive; they cover the medication, shipping, laboratory testing and virtual consultations. Because the service does not require insurance, patients avoid the administrative hurdles and co‑pay structures that often accompany traditional pharmacy benefits.
Potential results and considerations
MEDVi cites clinical data indicating that patients using GLP‑1 therapy can lose up to 20% of their body weight when combined with dietary and lifestyle changes. The company also offers a supplemental program called MEDVi Meals, which delivers pre‑prepared, nutritionally balanced meals to participants’ doors to support their weight‑loss goals.
While the lower‑cost compounded options may appeal to budget‑conscious consumers, experts note that compounded drugs are not FDA‑approved and may have variable potency. Patients are encouraged to discuss the differences between compounded and brand‑name products with their prescribing clinician.
Is MEDVi right for you?
MEDVi may be a viable option for individuals who prioritize convenience, want to avoid insurance paperwork, and are comfortable using compounded medications. Those who prefer FDA‑approved branded products should be prepared for higher monthly costs.
As with any prescription weight‑loss regimen, prospective users should consult a qualified healthcare professional to assess suitability, monitor side effects and ensure the treatment aligns with their overall health plan.
Original reporting: Las Cruces Sun News (HLL/CB) — read the source article.
